| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Fulcrum Therapeutics Inc (NASDAQ: FULC)
FULC Technical Analysis
5
| As on 9th Jun 2023 FULC STOCK Price closed @ 3.09 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 10.01 & Strong Sell for SHORT-TERM with Stoploss of 13.39 we also expect STOCK to react on Following IMPORTANT LEVELS. |
FULCSTOCK Price
| Open | 3.19 | Change | Price | % |
| High | 3.19 | 1 Day | -0.09 | -2.83 |
| Low | 3.08 | 1 Week | 0.37 | 13.60 |
| Close | 3.09 | 1 Month | 0.59 | 23.60 |
| Volume | 327500 | 1 Year | -14.68 | -82.61 |
| 52 Week High 24.00 | 52 Week Low 2.26 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| FULC Daily Charts |
FULC Intraday Charts |
Whats New @ Bazaartrend |
FULC Free Analysis |
|
|
FULC Important Levels Intraday
| RESISTANCE | 3.30 |
| RESISTANCE | 3.23 |
| RESISTANCE | 3.19 |
| RESISTANCE | 3.15 |
| SUPPORT | 3.03 |
| SUPPORT | 2.99 |
| SUPPORT | 2.95 |
| SUPPORT | 2.88 |
FULC Forecast May 2024
| 4th UP Forecast | 15.92 |
| 3rd UP Forecast | 11.81 |
| 2nd UP Forecast | 9.26 |
| 1st UP Forecast | 6.72 |
| 1st DOWN Forecast | -0.54 |
| 2nd DOWN Forecast | -3.08 |
| 3rd DOWN Forecast | -5.63 |
| 4th DOWN Forecast | -9.74 |
FULC Weekly Forecast
| 4th UP Forecast | 9.12 |
| 3rd UP Forecast | 7.19 |
| 2nd UP Forecast | 5.99 |
| 1st UP Forecast | 4.80 |
| 1st DOWN Forecast | 1.38 |
| 2nd DOWN Forecast | 0.19 |
| 3rd DOWN Forecast | -1.01 |
| 4th DOWN Forecast | -2.94 |
FULC Forecast2024
| 4th UP Forecast | 46.52 |
| 3rd UP Forecast | 32.59 |
| 2nd UP Forecast | 23.98 |
| 1st UP Forecast | 15.37 |
| 1st DOWN Forecast | -9.19 |
| 2nd DOWN Forecast | -17.8 |
| 3rd DOWN Forecast | -26.41 |
| 4th DOWN Forecast | -40.34 |
Fulcrum Therapeutics Inc ( NASDAQ USA Symbol : FULC )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
FULC Business Profile
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule that is in Phase 2b clinical trial for the treatment of facioscapulohumeral muscular dystrophy, a rare, progressive, and disabling muscle wasting disorder that leads to significant physical impairments and disability; and FTX-6058, a small molecule designed to upregulate fetal hemoglobin in patients with sickle cell disease and ß-thalassemia. The company is also discovering drug targets for the treatments of muscle, central nervous system, and hematologic disorders, as well as cardiomyopathies and pulmonary diseases. Fulcrum Therapeutics, Inc. has research and discovery collaboration agreement with Acceleron Pharma Inc. to identify biological targets to modulate specific pathways associated with a targeted indication within the pulmonary disease space; and has a strategic collaboration and license agreement with MyoKardia, Inc. to discover, develop, and commercialize novel targeted therapies for the treatment of genetic cardiomyopathies. Fulcrum Therapeutics, Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts. Address: 26 Landsdowne Street, Cambridge, MA, United States, 02139
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service